US Stock MarketDetailed Quotes
COCP Cocrystal Pharma
- 2.1500
- +0.0900+4.37%
Close Nov 21 16:00 ET
- 2.1500
- 0.00000.00%
Post 20:01 ET
21.87MMarket Cap-1168P/E (TTM)
2.2000High2.0011Low18.69KVolume2.0400Open2.0600Pre Close40.51KTurnover0.27%Turnover RatioLossP/E (Static)10.17MShares3.100052wk High1.72P/B15.08MFloat Cap1.325052wk Low--Dividend TTM7.01MShs Float77.4000Historical High--Div YieldTTM9.66%Amplitude1.3250Historical Low2.1670Avg Price1Lot Size
Cocrystal Pharma Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -91.09%-5.12M | 33.33%-3.7M | -44.74%-4.5M | 31.58%-14.67M | 32.03%-3.33M | 69.90%-2.68M | -48.98%-5.55M | 20.43%-3.11M | -62.97%-21.44M | -45.80%-4.89M |
| Net income from continuing operations | -18.58%-4.94M | -28.25%-5.34M | 23.76%-3.96M | 53.69%-17.98M | 0.82%-4.46M | 26.93%-4.17M | 82.95%-4.17M | -23.31%-5.19M | -173.79%-38.84M | -22.14%-4.5M |
| Operating gains losses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 75.51%-12K | --0 |
| Depreciation and amortization | -8.33%99K | 36.13%211K | -28.57%35K | -457.73%-1.39M | -1,800.00%-1.7M | 10.20%108K | 63.16%155K | -48.42%49K | 1.57%388K | 3.09%100K |
| Other non cash items | -21.05%-69K | ---- | ---- | 847.85%1.56M | 3,254.55%1.74M | -9.62%-57K | ---- | ---- | -187.45%-209K | -114.29%-55K |
| Change In working capital | -137.06%-467K | 184.82%1.36M | -142.52%-739K | 186.36%2.34M | 258.56%945K | 136.31%1.26M | -220.47%-1.6M | 6,852.00%1.74M | -1,695.29%-2.71M | -835.80%-596K |
| -Change in receivables | 392.45%1.04M | -457.22%-693K | 52.92%-113K | 75.70%-174K | 52.51%-340K | -34.97%212K | 159.51%194K | ---240K | -228.78%-716K | -12,033.33%-716K |
| -Change in prepaid assets | -166.06%-144K | 646.34%1.22M | 957.89%201K | 128.06%470K | -86.78%69K | 109.57%218K | 127.78%164K | 137.50%19K | -891.12%-1.68M | 201.73%522K |
| -Change in payables and accrued expense | ---- | ---- | -145.03%-883K | 737.38%2.05M | 402.49%1.22M | ---- | ---- | 11,435.29%1.96M | -47.93%-321K | -310.20%-402K |
| -Change in other current assets | ---- | ---- | 61.11%87K | ---- | ---- | ---- | ---- | --54K | ---- | ---- |
| -Change in other current liabilities | ---- | ---- | 44.64%-31K | ---- | ---- | ---- | ---- | ---56K | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -91.09%-5.12M | 33.33%-3.7M | -44.74%-4.5M | 31.58%-14.67M | 32.03%-3.33M | 69.90%-2.68M | -48.98%-5.55M | 20.43%-3.11M | -68.53%-21.44M | -67.45%-4.89M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | 0 | 82.22%-8K | -59.46%-118K | -391.67%-59K | 0 | -14K | -45K | -42.31%-74K | -50.00%-12K |
| Net PPE purchase and sale | --0 | --0 | 82.22%-8K | -59.46%-118K | -391.67%-59K | --0 | ---14K | ---45K | -42.31%-74K | -50.00%-12K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | --0 | --0 | 82.22%-8K | -59.46%-118K | -391.67%-59K | --0 | ---14K | ---45K | -42.31%-74K | -50.00%-12K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 0 | 0 | 0 | 14,888.89%3.99M | 0 | 0 | 57,242.86%4M | -16.67%-7K | -100.07%-27K | 22.22%-7K |
| Net issuance payments of debt | --0 | --0 | --0 | 74.07%-7K | --0 | --0 | --0 | -16.67%-7K | 30.77%-27K | 22.22%-7K |
| Net common stock issuance | --0 | ---- | ---- | --4M | --0 | --0 | ---- | ---- | --0 | --0 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | --0 | --0 | --0 | 14,888.89%3.99M | --0 | --0 | 57,242.86%4M | -16.67%-7K | -100.07%-27K | 22.22%-7K |
| Net cash flow | ||||||||||
| Beginning cash position | -43.93%18.22M | -35.64%21.92M | -28.99%26.43M | -36.65%37.22M | -29.24%29.81M | -36.42%32.49M | -37.90%34.06M | -36.65%37.22M | 77.72%58.76M | -31.71%42.13M |
| Current changes in cash | -91.09%-5.12M | -136.81%-3.7M | -42.62%-4.51M | 49.89%-10.79M | 31.78%-3.39M | 69.97%-2.68M | 58.13%-1.56M | 19.23%-3.16M | -183.81%-21.54M | -68.83%-4.96M |
| End cash Position | -56.08%13.1M | -43.93%18.22M | -35.64%21.92M | -28.99%26.43M | -28.99%26.43M | -29.24%29.81M | -36.42%32.49M | -37.90%34.06M | -36.65%37.22M | -36.65%37.22M |
| Free cash flow | -91.09%-5.12M | 33.50%-3.7M | -42.93%-4.51M | 31.27%-14.78M | 30.99%-3.39M | 70.11%-2.68M | -49.36%-5.56M | 19.28%-3.16M | -68.42%-21.51M | -67.41%-4.91M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data